Diagnostic significance of pregnancy-associated alpha 2-glycoprotein in patients with ovarian cancer.
D000230:Adenocarcinoma / Q000032:analysis / Q000175:diagnosis; D000328:Adult; D000818:Animals; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002294:Carcinoma, Squamous Cell / Q000032:analysis / Q000175:diagnosis; D002822:Choriocarcinoma / Q000032:analysis / Q000175:diagnosis; D004407:Dysgerminoma / Q000032:analysis / Q000175:diagnosis; D005260:Female; D006801:Humans; D007122:Immunoelectrophoresis; D008649:Mesonephroma / Q000032:analysis / Q000175:diagnosis; D051379:Mice; D008819:Mice, Nude; D008875:Middle Aged; D009368:Neoplasm Transplantation; D010051:Ovarian Neoplasms / Q000032:analysis* / Q000175:diagnosis; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000032:analysis*; D011266:Pregnancy-Associated Plasma Protein-A / Q000032:analysis*; D013724:Teratoma / Q000032:analysis / Q000175:diagnosis; D000509:alpha-Fetoproteins / Q000032:analysis
D002272:Carcinoembryonic Antigen; D011257:Pregnancy Proteins; D000509:alpha-Fetoproteins; D011266:Pregnancy-Associated Plasma Protein-A